Table 2 Participants demographics (n = 322)
Demographic characteristics | Frequency n (%) |
|---|---|
Sex | |
Female | 202 (62.5) |
Male | 115 (35.7) |
I prefer not to disclose | 5 (1.6) |
Age | |
19 or younger | 2 (0.6) |
20–29 | 49 (15.2) |
30–39 | 100 (31.1) |
40–49 | 83 (25.8) |
50–59 | 63 (19.6) |
60–69 | 23 (7.1) |
70 and older | 2 (0.6) |
Experience with AGREE II | |
No experience | 70 (21.7) |
Some experience | 122 (37.9) |
Experienced | 88 (27.3) |
Very experienced | 42 (13) |
Geographic location | |
North America | 177 (55) |
Europe | 76 (23.6) |
Asia | 24 (7.5) |
South America | 32 (9.9) |
Africa | 7 (2.2) |
Oceania | 6 (1.9) |
First language | |
English | 188 (58.4) |
Spanish | 51 (15.8) |
Italian | 14 (4.3) |
Chinese | 13 (4) |
Dutch | 10 (3.1) |
Portuguese | 7 (2.2) |
French | 4 (1.2) |
Greek | 3 (0.9) |
Ukrainian | 3 (0.9) |
Other | 29 (9) |
Participants’ roles with clinical practice guidelines (PG)a | |
CPG developer—clinical expert | 85 (26.4) |
CPG developer—patient/public representative | 15 (4.7) |
CPG developer—methodologist | 170 (52.8) |
CPG user—health care provider | 102 (31.7) |
CPG user—administrator/policy maker/manager | 38 (11.8) |
CPG user—patient/member of the public | 20 (6.2) |
Researcher | 159 (49.4) |
Other (e.g., librarian, student) | 25 (7.8) |